Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 19 studies | 32% ± 13% | |
smooth muscle cell | 16 studies | 28% ± 11% | |
pericyte | 11 studies | 22% ± 7% | |
astrocyte | 9 studies | 26% ± 13% | |
adipocyte | 9 studies | 39% ± 19% | |
myofibroblast cell | 5 studies | 20% ± 4% | |
hematopoietic stem cell | 5 studies | 33% ± 21% | |
connective tissue cell | 4 studies | 39% ± 19% | |
GABAergic neuron | 4 studies | 24% ± 7% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 43% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipose | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3423.42 | 576 / 578 | 84% | 4.50 | 968 / 1155 |
prostate | 93% | 1272.61 | 229 / 245 | 88% | 5.71 | 442 / 502 |
thymus | 90% | 804.09 | 585 / 653 | 75% | 3.66 | 453 / 605 |
breast | 87% | 973.06 | 401 / 459 | 65% | 2.25 | 722 / 1118 |
adrenal gland | 60% | 354.95 | 154 / 258 | 73% | 3.51 | 168 / 230 |
kidney | 57% | 444.53 | 51 / 89 | 73% | 6.85 | 659 / 901 |
esophagus | 62% | 1238.82 | 893 / 1445 | 67% | 3.41 | 123 / 183 |
ovary | 73% | 620.40 | 132 / 180 | 33% | 0.96 | 144 / 430 |
stomach | 46% | 553.30 | 164 / 359 | 60% | 1.68 | 173 / 286 |
bladder | 57% | 393.29 | 12 / 21 | 49% | 2.10 | 245 / 504 |
intestine | 58% | 412.51 | 562 / 966 | 45% | 1.10 | 238 / 527 |
skin | 43% | 1902.33 | 785 / 1809 | 58% | 8.52 | 272 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.14 | 1 / 1 |
blood vessel | 99% | 3548.28 | 1328 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 1842.19 | 1177 / 1204 | 0% | 0 | 0 / 0 |
brain | 21% | 112.25 | 553 / 2642 | 75% | 4.63 | 526 / 705 |
uterus | 61% | 490.12 | 104 / 170 | 34% | 1.77 | 156 / 459 |
muscle | 72% | 663.32 | 576 / 803 | 0% | 0 | 0 / 0 |
pancreas | 2% | 9.88 | 7 / 328 | 69% | 1.98 | 122 / 178 |
spleen | 65% | 517.34 | 157 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.67 | 23 / 45 |
heart | 44% | 324.28 | 383 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 1.56 | 1 / 226 | 43% | 1.06 | 175 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
peripheral blood | 0% | 0.37 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0032680 | Biological process | regulation of tumor necrosis factor production |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0030097 | Biological process | hemopoiesis |
GO_0007171 | Biological process | activation of transmembrane receptor protein tyrosine kinase activity |
GO_0001701 | Biological process | in utero embryonic development |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0030210 | Biological process | heparin biosynthetic process |
GO_0050918 | Biological process | positive chemotaxis |
GO_0043116 | Biological process | negative regulation of vascular permeability |
GO_2000446 | Biological process | regulation of macrophage migration inhibitory factor signaling pathway |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0034394 | Biological process | protein localization to cell surface |
GO_0002092 | Biological process | positive regulation of receptor internalization |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0014842 | Biological process | regulation of skeletal muscle satellite cell proliferation |
GO_0048014 | Biological process | Tie signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0072012 | Biological process | glomerulus vasculature development |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_1905605 | Biological process | positive regulation of blood-brain barrier permeability |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0002719 | Biological process | negative regulation of cytokine production involved in immune response |
GO_0001936 | Biological process | regulation of endothelial cell proliferation |
GO_0005902 | Cellular component | microvillus |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | ANGPT1 |
Protein name | Angiopoietin 1 Angiopoietin-1 (ANG-1) Angiopoietin-1 |
Synonyms | KIAA0003 |
Description | FUNCTION: Binds and activates TEK/TIE2 receptor by inducing its dimerization and tyrosine phosphorylation. Plays an important role in the regulation of angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Required for normal angiogenesis and heart development during embryogenesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. Mediates blood vessel maturation/stability. Implicated in endothelial developmental processes later and distinct from that of VEGF. Appears to play a crucial role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme. . |
Accessions | ENST00000297450.7 [Q15389-2] E5RFF4 E7ERK4 ENST00000520033.1 Q15389 ENST00000520052.1 ENST00000517746.6 [Q15389-1] B4DTQ9 ENST00000520734.5 |